Opexa Therapeutics Is A Biotechnology Company Based In The Woodlandstexasfocused On Developing Personalized Immunotherapies For Autoimmune Diseasesparticularly Multiple Sclerosismsand Neuromyelitis Opticafounded In 2003The Company Specializes In Patient Specific Cellular Therapies Using Proprietary T Cell Technology To Create Tailored Treatments That Aim To Improve Efficacysafetyand Tolerability For Patients The Company S Lead Product Candidates Include Tovaxina Novel T Cell Vaccine Designed For Msand Tcelnaa Personalized T Cell Immunotherapy For Secondary Progressive Multiple Sclerosisspms Tovaxin Has Shown Promising Results In Reducing Relapse Rates In Clinical Studieswhile Tcelna Is Being Evaluated In The Abili T Trial For Its Effectiveness In Spms Patientsopexa Has Collaborated With Major Pharmaceutical Companiesincluding Merck Seronoto Advance Its Research And Development Efforts
No conferences found for this company.
| Company Name | Opexa Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
